关注
Leslie Citrome
Leslie Citrome
New York Medical College
在 cnsconsultant.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
9432017
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
RM Bilder, RS Goldman, J Volavka, P Czobor, M Hoptman, B Sheitman, ...
American Journal of Psychiatry 159 (6), 1018-1028, 2002
7562002
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics
JP Lindenmayer, P Czobor, J Volavka, L Citrome, B Sheitman, JP McEvoy, ...
American Journal of Psychiatry 160 (2), 290-296, 2003
7202003
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
J Volavka, P Czobor, B Sheitman, JP Lindenmayer, L Citrome, JP McEvoy, ...
American Journal of Psychiatry 159 (2), 255-262, 2002
5952002
Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia
RM Bilder, J Volavka, P ál Czobor, AK Malhotra, JL Kennedy, X Ni, ...
Biological psychiatry 52 (7), 701-707, 2002
4472002
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder
MI Krakowski, P Czobor, L Citrome, N Bark, TB Cooper
Archives of General Psychiatry 63 (6), 622-629, 2006
4112006
Good publication practice for communicating company-sponsored medical research: GPP3
WP Battisti, E Wager, L Baltzer, D Bridges, A Cairns, CI Carswell, ...
Annals of Internal Medicine 163 (6), 461-464, 2015
3602015
The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence
CU Correll, L Citrome, PM Haddad, J Lauriello, M Olfson, SM Calloway, ...
The Journal of clinical psychiatry 77 (suppl 3), 21984, 2016
3592016
Antipsychotic-induced weight gain and therapeutic response: a differential association
P Czobor, J Volavka, B Sheitman, JP Lindenmayer, L Citrome, J McEvoy, ...
Journal of clinical psychopharmacology 22 (3), 244-251, 2002
2862002
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
L Citrome, J Volavka, P Czobor, B Sheitman, JP Lindenmayer, J McEvoy, ...
Psychiatric Services 52 (11), 1510-1514, 2001
2862001
Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol
J Volavka, P Czobor, K Nolan, B Sheitman, JP Lindenmayer, L Citrome, ...
Journal of clinical psychopharmacology 24 (2), 225-228, 2004
2492004
When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed
L Citrome, TA Ketter
International journal of clinical practice 67 (5), 407-411, 2013
2452013
Pathways to aggression in schizophrenia affect results of treatment
J Volavka, L Citrome
Schizophrenia bulletin 37 (5), 921-929, 2011
2392011
Heterogeneity of violence in schizophrenia and implications for long‐term treatment
J Volavka, L Citrome
International journal of clinical practice 62 (8), 1237-1245, 2008
2222008
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.
JP Lindenmayer, H Liu-Seifert, PM Kulkarni, BJ Kinon, V Stauffer, ...
Journal of Clinical Psychiatry 70 (7), 990, 2009
2022009
Characteristics of assaultive behavior among psychiatric inpatients
KA Nolan, P Czobor, BB Roy, MM Platt, CB Shope, LL Citrome, J Volavka
Psychiatric services 54 (7), 1012-1016, 2003
1962003
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol
J Volavka, P Czobor, TB Cooper, B Sheitman, JP Lindenmayer, L Citrome, ...
Journal of Clinical Psychiatry 65 (1), 57-61, 2004
1882004
Compelling or irrelevant? Using number needed to treat can help decide
L Citrome
Acta Psychiatrica Scandinavica 117 (6), 412-419, 2008
1872008
Lurasidone for schizophrenia: A review of the efficacy and safety profile for this newly approved second‐generation antipsychotic
L Citrome
International journal of clinical practice 65 (2), 189-210, 2011
1712011
An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels
J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ...
Pharmacopsychiatry 55 (02), 73-86, 2022
1692022
系统目前无法执行此操作,请稍后再试。
文章 1–20